Has Jennifer Domm received payments from drug or device companies?

Yes. Drug and device makers reported $396,082 in general payments to Jennifer Domm across 585 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jennifer Domm did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jennifer Domm come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jennifer Domm

Pediatric Hematology-Oncology · Nashville, TNNPI 1558395665

Payments from drug & device makers

$396,082in general payments, 2019–2025

Across 585 payments — averaging $677.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$321K
Novo Nordisk AS$26K
Pfizer$17K
Novartis$11K
CSL Behring$8K
Takeda Pharmaceuticals U.S.A., Inc.$3K
plus $11K from 54 others

What the payments were for

Consulting fees$45,10313%
Speaking & faculty fees$240,52267%
Travel & lodging$63,49818%
Food & beverage$10,2983%
Entertainment$240%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	278	$320,756
Novo Nordisk AS	99	$25,810
Pfizer	27	$16,713
Novartis	12	$11,056
CSL Behring	16	$8,400
Takeda Pharmaceuticals U.S.A., Inc.	8	$2,773
Adaptive Biotechnologies Corporation	7	$2,511
Biomarin Pharmaceutical Inc.	1	$1,900
Pharmacosmos Therapeutics Inc.	4	$1,638
BD	1	$400
Recordati_rare_diseases_inc.	1	$353
Tersera Therapeutics LLC	1	$313
Dr.reddy's Laboratories,inc.	1	$245
Sobi, Inc	8	$216
AstraZeneca	3	$209
Pharming Healthcare, Inc.	7	$164
Amgen	8	$142
Biogen	6	$134
Vertex	1	$124
Jazz Pharmaceuticals Inc.	4	$124
Springworks Therapeutics, Inc.	5	$123
Octapharma USA, Inc.	2	$114
Sanofi	4	$110
Agios Pharmaceuticals, Inc.	5	$108
UCB, Inc.	3	$101
Azurity Pharmaceuticals, Inc.	5	$97
USWM, LLC	3	$97
Insulet Corporation	6	$94
Syndax Pharmaceuticals, Inc.	3	$75
HEMA Biologics, LLC	4	$73
Endo Pharmaceuticals Inc.	4	$71
Krystal Biotech Inc	3	$68
Y-mabs Therapeutics, Inc.	3	$66
Mesoblast, Inc.	2	$62
Arbor Pharmaceuticals, Inc.	3	$53
Genentech USA, Inc.	2	$50
Aptevo Therapeutics Inc	2	$50
Catalyst Pharmaceuticals, Inc.	2	$49
Day One Biopharmaceuticals	2	$48
Sanofi-aventis U.S. LLC	2	$43
Kerecis Limited	1	$40
Medexus Pharma, Inc.	2	$40
Grifols USA, LLC	2	$35
Corium, LLC	1	$35
Ultragenyx Pharmaceutical Inc.	1	$32
Seagen Inc.	2	$31
Bayer	1	$30
Companion Medical, Inc.	2	$29
Ipsen Biopharmaceuticals, Inc	1	$28
Aquestive Therapeutics, Inc.	1	$26
Immedica Pharma US, Inc.	1	$22
SK Life Science, Inc.	1	$22
Amneal Pharmaceuticals LLC	1	$20
Livanova USA, Inc.	1	$19
Mirum Pharmaceuticals, Inc.	1	$18
Ferring Pharmaceuticals Inc.	1	$17
Johnson & Johnson	1	$16
Aucta Pharmaceuticals, Inc.	1	$16
AbbVie	1	$16
Phadia US Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NovoSeven$51,154
REBINYN$50,144
Esperoct$35,060
Alhemo$33,479
HYMPAVZI$9,464
HEMGENIX$7,879
NovoSeven RT$6,545
OXBRYTA$5,393
Idelvion$4,229
ICLUSIG$2,640
clonoSEQ$2,086
Roctavian$1,900
Monoferric$1,500
ULTOMIRIS$175
CASGEVY$124

How this compares

$396,082 in reported general payments places this provider in the 80th percentile of 113 pediatric hematology-oncology providers in Tennessee.

See all pediatric hematology-oncology providers in Tennessee →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	14	$200
Omeprazole	11	$195

Paid to pharmacies, not to this prescriber.

Other pediatric hematology-oncology in Nashville

Haydar FrangoulNashville$22.5M
Alexandra BorstNashville$3.1M
Carrie KitkoNashville$977K
Scott BorinsteinNashville$621K
Meghann McManusNashville$271K
Michael DebaunNashville$182K
Debra FriedmanNashville$112K
Heather McDanielNashville$106K
Elizabeth YangNashville$56K
James ConnellyNashville$47K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →